187 related articles for article (PubMed ID: 2408732)
1. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.
Maruo T; Shibata K; Kimura A; Hoshina M; Mochizuki M
Cancer; 1985 Jul; 56(2):302-8. PubMed ID: 2408732
[TBL] [Abstract][Full Text] [Related]
2. Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer.
Kato H; Morioka H; Tsutsui H; Aramaki S; Torigoe T
Cancer; 1982 Oct; 50(7):1294-6. PubMed ID: 7104971
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen in carcinoma of the uterine cervix: antigen distribution in primary and metastatic tumors.
van Nagell JR; Hudson S; Gay EC; Donaldson ES; Hanson M; Powell DF; Goldenberg DM
Cancer; 1982 Jan; 49(2):379-83. PubMed ID: 6274508
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of tumor associated antigen TA-4 in gynecologic tumors].
Inoue Y; Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Nishino T; Saito J; Abe Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):919-22. PubMed ID: 3894536
[TBL] [Abstract][Full Text] [Related]
5. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
Hsieh CY; Chang DY; Huang SC; Yen ML; Juang GT; Ouyang PC
Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):797-800. PubMed ID: 2592943
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma.
Senekjian EK; Young JM; Weiser PA; Spencer CE; Magic SE; Herbst AL
Am J Obstet Gynecol; 1987 Aug; 157(2):433-9. PubMed ID: 3475982
[TBL] [Abstract][Full Text] [Related]
7. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation.
Kato H; Nagaya T; Torigoe T
Gan; 1984 May; 75(5):433-5. PubMed ID: 6745563
[TBL] [Abstract][Full Text] [Related]
9. [Determination of the SCC antigen in the serum of patients with cervical cancer].
Crombach G; Würz H; Bolte A
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors.
Ueda G; Inoue Y; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Saito J; Nishino T; Abe Y
Int J Gynecol Pathol; 1984; 3(3):291-8. PubMed ID: 6389386
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies.
Kato H; Suehiro Y; Morioka H; Torigoe T; Myoga A; Sekiguchi K; Ikeda I
Jpn J Cancer Res; 1987 Nov; 78(11):1246-50. PubMed ID: 3121560
[TBL] [Abstract][Full Text] [Related]
12. Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix.
Crombach G; Scharl A; Vierbuchen M; Würz H; Bolte A
Cancer; 1989 Apr; 63(7):1337-42. PubMed ID: 2920361
[TBL] [Abstract][Full Text] [Related]
13. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
[TBL] [Abstract][Full Text] [Related]
14. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ
Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
[TBL] [Abstract][Full Text] [Related]
15. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs.
Mino N; Iio A; Hamamoto K
Cancer; 1988 Aug; 62(4):730-4. PubMed ID: 2840187
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix.
Kato H; Morioka H; Aramaki S; Tamai K; Torigoe T
Am J Obstet Gynecol; 1983 Feb; 145(3):350-4. PubMed ID: 6824024
[TBL] [Abstract][Full Text] [Related]
17. Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma.
Kato H; Tamai K; Morioka H; Nagai M; Nagaya T; Torigoe T
Cancer; 1984 Oct; 54(8):1544-6. PubMed ID: 6478396
[TBL] [Abstract][Full Text] [Related]
18. Tumor antigen of human cervical squamous cell carcinoma: correlation of circulating levels with disease progress.
Kato H; Miyauchi F; Morioka H; Fujino T; Torigoe T
Cancer; 1979 Feb; 43(2):585-90. PubMed ID: 421183
[TBL] [Abstract][Full Text] [Related]
19. Serum level of squamous cell carcinoma antigen and tumor size are useful to identify preoperatively patients at high risk of cervical cancer.
Chou CY; Wang ST; Kuo HC; Tzeng CC; Yao BL
Cancer; 1994 Nov; 74(9):2497-501. PubMed ID: 7923006
[TBL] [Abstract][Full Text] [Related]
20. [Prediction of the recurrence of squamous cell carcinoma of the uterine cervix by monitoring serum TA-4].
Oishi T; Maruo T; Yamasaki M; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):799-806. PubMed ID: 3598275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
